Guoliang Qiao

机构：Zhejiang Chinese Medical University, First Affiliated Hospital Zhejiang University

发表论文 98 篇 · 总被引 1038 次 · h-index 17

代表论文

• 5-Year survival rate over 20 % in pancreatic ductal adenocarcinoma: A retrospective study from a Chinese high-volume center (2025 · Cancer Letters · 被引 18)
• Precision-cut liver slices as an ex vivo model to evaluate antifibrotic therapies for liver fibrosis and cirrhosis (2024 · Hepatology Communications · 被引 17)
• Neoadjuvant nab-paclitaxel plus gemcitabine followed by modified FOLFIRINOX for resectable pancreatic cancer: A randomized phase 3 trial (2025 · Cancer Cell · 被引 15)
• Optimizing perioperative treatment for potentially resectable stage III squamous cell lung carcinoma: promising results of a condensed four-cycle regimen with tislelizumaband chemotherapy (2024 · BMC Medicine · 被引 9)
• Tumor Size Reduction and Serum Carbohydrate Antigen 19-9 Kinetics After Neoadjuvant FOLFIRINOX in Patients With Pancreatic Ductal Adenocarcinoma (2023 · Surgery · 被引 7)
• Precision-Cut Liver Slices as an ex vivo model to evaluate antifibrotic therapies for liver fibrosis and cirrhosis (2023 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 4)